Soligenix, Inc. Files 8-K: Director Changes & Shareholder Votes
Ticker: SNGX · Form: 8-K · Filed: Jun 20, 2025 · CIK: 812796
| Field | Detail |
|---|---|
| Company | Soligenix, Inc. (SNGX) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, board-of-directors, shareholder-vote
TL;DR
Soligenix board shakeup and shareholder votes - check the details.
AI Summary
Soligenix, Inc. filed an 8-K on June 20, 2025, reporting on several key events. These include the departure of a director, the election of new directors, and updates to compensatory arrangements for certain officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing provides crucial updates on the company's governance and strategic direction, including changes in its board of directors and matters put before shareholders.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate shifts in company strategy or internal dynamics that may affect future performance.
Key Players & Entities
- Soligenix, Inc. (company) — Filer of the 8-K report
- June 20, 2025 (date) — Date of the earliest event reported
- DELAWARE (jurisdiction) — State of incorporation
FAQ
What specific items were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
Who is the departing director?
The filing mentions the departure of a director but does not specify the name of the individual in the provided text.
Are there any new directors elected?
Yes, the filing states the election of directors as an item reported.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
What is Soligenix, Inc.'s SIC code?
Soligenix, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding SOLIGENIX, INC. (SNGX).